Lista de obras -

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

artículo científico publicado en 2011

Abacavir-reactive memory T cells are present in drug naïve individuals

artículo científico publicado en 2015

Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis

artículo científico publicado en 2012

Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein

artículo científico publicado en 2015

B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade

artículo científico publicado en 2013

Cellular Immunity for Prevention and Clearance of HIV Infection ⬇️

artículo científico publicado el 1 de mayo de 2003

Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis

artículo científico publicado en 2006

Characteristics of the earliest cross-neutralizing antibody response to HIV-1.

artículo científico publicado en 2011

Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo

artículo científico publicado en 2010

Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients.

artículo científico publicado en 2014

Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses

artículo científico publicado en 2003

Cytomegalovirus (CMV) Epitope-Specific CD4(+) T Cells Are Inflated in HIV(+) CMV(+) Subjects

artículo científico publicado en 2017

DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults

artículo científico publicado en 2012

Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes

artículo científico publicado en 2003

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

artículo científico publicado en 2016

Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1

artículo científico publicado en 2014

Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.

artículo científico publicado en 2014

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

artículo científico publicado en 2008

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

artículo científico publicado en 2015

Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire

artículo científico publicado en 2005

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

artículo científico publicado en 2011

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein

artículo científico publicado en 2016

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection

artículo científico publicado en 2007

Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL ⬇️

artículo científico publicado el 1 de octubre de 2003

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth

scientific article published in PLoS ONE

Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis

artículo científico publicado en 2011

Kinetic Analysis by Real-Time PCR of Hepatitis C Virus (HCV)-Specific T Cells in Peripheral Blood and Liver after Challenge with HCV

artículo científico publicado en 2008

Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape

artículo científico publicado en 2004

Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection

artículo científico publicado en 2005

Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant

scientific article published on 10 June 2009

Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.

artículo científico publicado en 2016

Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384

artículo científico publicado en 2011

Multiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry.

artículo científico publicado en 2015

Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis

artículo científico publicado en 2007

Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.

artículo científico publicado en 2016

OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysis

artículo científico publicado en 2014

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

artículo científico publicado en 2011

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

artículo científico publicado en 2014

Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.

artículo científico publicado en 2011

Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

artículo científico publicado en 2009

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

artículo científico publicado en 2015

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

artículo científico publicado en 2013

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

artículo científico publicado en 2008

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults

artículo científico publicado en 2012

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

artículo científico publicado en 2014

Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals

artículo científico publicado en 2008

T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.

artículo científico publicado en 2012

The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy

artículo científico publicado en 2015

The potential role of epitope-specific T-cell receptor diversity in the control of HIV replication

artículo científico publicado en 2007

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

artículo científico publicado en 2015

Lista de obras de

A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)

Abacavir-reactive memory T cells are present in drug naïve individuals

Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis

Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein

B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade

Cellular Immunity for Prevention and Clearance of HIV Infection ⬇️

Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis

Characteristics of the earliest cross-neutralizing antibody response to HIV-1.

Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo

Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients.

Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses

Cytomegalovirus (CMV) Epitope-Specific CD4(+) T Cells Are Inflated in HIV(+) CMV(+) Subjects

DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults

Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1

Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire

HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection

Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL ⬇️

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth

Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis

Kinetic Analysis by Real-Time PCR of Hepatitis C Virus (HCV)-Specific T Cells in Peripheral Blood and Liver after Challenge with HCV

Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape

Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection

Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant

Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster.

Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384

Multiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry.

Mycobacterium tuberculosis Antigen 85A induces Th-1 immune responses in systemic sarcoidosis

Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.

OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysis

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.

Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial

Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals

T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.

The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy

The potential role of epitope-specific T-cell receptor diversity in the control of HIV replication

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083